Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-13-005619
Filing Date
2013-02-12
Accepted
2013-02-12 17:08:39
Documents
1
Period of Report
2013-02-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 9390
  Complete submission text file 0001127602-13-005619.txt   10937
Mailing Address 133 BOSTON POST ROAD WESTON MA 02493
Business Address 133 BOSTON POST ROAD WESTON MA 02493 7814642000
BIOGEN IDEC INC. (Issuer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O AMGEN INC ONE AMGEN CENTER DR THOUSAND OAKS CA 91320-1799
Business Address
WILLIAMS DOUGLAS E (Reporting) CIK: 0001184847 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19311 | Film No.: 13598126